Effects of Empowerment Program Integrated With Family Support on Maternal Self-esteem and Quality of Life Among Palestinian Pregnant Adolescents

November 15, 2023 updated by: Shurouq Ghalib Mousa Qadous, Prince of Songkla University

The Effects of Empowerment Program Integrated With Family Support on Maternal Self-Esteem and Quality of Life Among Pregnant Adolescents in Palestine: A Randomized Controlled Trial

Adolescent pregnancy leads to increase risks and complications for the adolescent mother and her newborn. This study aims to examine the effects of empowerment program integrated with family support on maternal self-esteem and quality of life among Palestinian pregnant adolescents. A randomized controlled single-blind trial, pretest-posttest controlled group design will be conducted with 62 participants ( control group =31, experimental group = 31). Research instruments will include the instruments for data collection, instruments for research intervention, and control instruments for intervention evaluation. The instruments for data collection will be consists of a demographic data form, Maternal Self-Report Inventory (MSRI), and WHO quality of life-BREF (WHOQoL-BREF, 1997). The empowerment program integrated with family support will be the research intervention instruments and included five steps; step 1: building relationships and creating collaboration, step 2: discovering reality, step 3: critical reflection, step 4: taking charge, and step 5: holding on. Control instruments through Family Support Questionnaire (FSQ) will be used to evaluate the effectiveness of the intervention program. Data will be analyzed using mean and standard deviations, frequency distribution, percentage, and chi-square test, and t-test. This program is expected to guide nurses to empower pregnant adolescents in enhancing maternal self-esteem and improve their quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 20 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age from 15 to 20 years.
  2. First-time pregnant.
  3. Have a single fetus.
  4. Gestational age 32 or 33 weeks.
  5. Medical history free from diseases such as diabetes mellitus (DM), hypertension, urinary tract infections (UTIs), heart disease, and thyroid disease.
  6. Free of complications during the present pregnancy such as preterm labor and gestational hypertension.
  7. Have more than check answers on the perinatal screening depression checklist (adopted from Edinburgh Postnatal Depression Scale).
  8. Having their own family member (pregnant adolescents' husband, own mother, mother-in-law, her sister, or sister-in-law) during giving the intervention.
  9. Able to read, write, and communicate clearly in the Arabic language.
  10. Living in Nablus City.

The family member will be included in any of the following criteria are present.

  1. Being with the pregnant adolescent during the intervention and continue giving support at home.
  2. The available phone number for contact while family members are at home.

Exclusion Criteria:

  1. Pregnant adolescents who experience any serious obstetric complications during the study such as preterm labor, gestational hypertension, and bleeding disorders.
  2. Pregnant adolescent who is not able to follow or complete the intervention program.
  3. Family member who is unable to accompany the pregnant adolescent during the intervention delivery at the primary health care clinic.
  4. Family member who is unable to give social support to the pregnant adolescent at home.
  5. Pregnant adolescents or family members in case one of them withdraws from the study the other will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
For the control group, the researcher will provide routine care to pregnant adolescents.
Experimental: Experimental group
For the experimental group, the researcher will provide the empowered program integrated with family support plus routine care.
Other: Empowered program integrated with family support
The empowered program integrated with family support is an intervention consisted of five steps that will be given when pregnant adolescents on gestational age 32 or 33 weeks the second meeting will be when the pregnant adolescents on gestational age 34 or 35 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal Self-Esteem (MSE)
Time Frame: Measure MSE at 32 weeks gestation or 33 weeks gestation (Preintervention)
Used Maternal Self Report Inventory-Short Form (MSRI-SF)
Measure MSE at 32 weeks gestation or 33 weeks gestation (Preintervention)
Quality of Life (QoL)
Time Frame: Measure QoL at 32 weeks gestation or 33 weeks gestation (Preintervention)
Used World Health Organization Quality of Life- BREF (WHOQoL-BREF)
Measure QoL at 32 weeks gestation or 33 weeks gestation (Preintervention)
Maternal Self-Esteem (MSE)
Time Frame: Measure MSE at 36 weeks gestation or 37 weeks gestation (Postintervention)
Used Maternal Self Report Inventory-Short Form (MSRI-SF)
Measure MSE at 36 weeks gestation or 37 weeks gestation (Postintervention)
Quality of Life (QoL)
Time Frame: Measure QoL at 36 weeks gestation or 37 weeks gestation (Postintervention)
Used World Health Organization Quality of Life- BREF (WHOQoL-BREF)
Measure QoL at 36 weeks gestation or 37 weeks gestation (Postintervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Prince of Songkla University

Investigators

  • Principal Investigator: Shurouq Qadous, Prince Songkla University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2021

Primary Completion (Actual)

June 20, 2022

Study Completion (Actual)

August 22, 2022

Study Registration Dates

First Submitted

August 20, 2021

First Submitted That Met QC Criteria

August 28, 2021

First Posted (Actual)

September 1, 2021

Study Record Updates

Last Update Posted (Estimated)

November 17, 2023

Last Update Submitted That Met QC Criteria

November 15, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • PSU IRB 2021-St-Nur 009

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnant Adolescents

Clinical Trials on Empowered program integrated with family support

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe